3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Neoplasms
8
Prostatic Neoplasms
7
Leukemia, Myeloid, Acute
6
Colorectal Neoplasms
5
Breast Neoplasms
5
Stomach Neoplasms
4
Leukemia, Myelomonocytic, Acute
4
Leukemia, Monocytic, Acute
4
Leukemia, Megakaryoblastic, Acute
4
Leukemia, Erythroblastic, Acute
4
Congenital Abnormalities
4
Pancreatic Neoplasms
3
Multiple Myeloma
3
Lymphoma, Mantle-Cell
3
Lung Neoplasms
3
Colonic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Venous Thromboembolism
2
Recurrence
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Papillomavirus Infections
2
Neuroblastoma
2
Neoplasm Metastasis
2
Motor Activity
2
Melanoma
2
Lymphoma, Follicular
2
Lymphoma
2
Leukemia, Eosinophilic, Acute
2
Leukemia, Basophilic, Acute
2
Interventions
Doxorubicin
18
Vincristine
15
Zidovudine
11
Bleomycin
11
Cyclophosphamide
9
Etoposide
8
Interferon alpha-2
6
Prednisone
5
Cytarabine
5
tecogalan
4
sargramostim
4
Rituximab
4
Polymerase Chain Reaction
4
Liposomes
4
Filgrastim
4
Dexamethasone
4
Methotrexate
3
Leucovorin
3
Fluorouracil
3
interferon alfa-n1
2
Watchful Waiting
2
Vinblastine
2
Tumor Necrosis Factor-alpha
2
Thalidomide
2
Semaxinib
2
Ritonavir
2
Peripheral Blood Stem Cell Transplantation
2
Mitoxantrone
2
Light Coagulation
2
Isotretinoin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
HIV Infections
×
Observation
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts